CELH— AI Stock Forecast & Price Targets
Published 5/21/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live CELH price forecast →
CELH has been crushed (-35% in 3 months, now $28.63 vs 52w high $66.74), but Q1 2026 results show the Alani Nu integration is delivering: revenue $782.6M with operating margin rebounding to 18.3% and net income of $110M. The Kronos forecasts are constructively bullish on 1h/4h horizons (targets $34-$48) but the model's own track record at longer horizons is poor (25-33% directional accuracy beyond 4 days), so the setup favors a tactical accumulation rather than a high-conviction long.
Tactical long bias near $28.60 with stop below $27.50 (breaks 52w low and invalidates the support thesis). Target 1: $32 (gap fill). Target 2: $34-35 (Kronos 1h forecast and prior consolidation high). Risk:reward ~1:3. Size modestly (1-2% portfolio) — Kronos 1-day accuracy of 71% supports the setup but longer-horizon model accuracy is poor. Take partials at $32.
Constructive over 1-6 months. Thesis: Q1'26 results validate the Alani Nu deal is accretive, forward P/E of 14x is undemanding for a beverage company growing revenue >50% YoY, and the stock is washed out. Expected return range: +20% to +50% to $34-43 (aligning with daily/4h Kronos targets). Catalysts: next earnings print (margin trajectory), summer beverage seasonality, distribution win announcements. Mind-changers: a guide-down on margins, loss of shelf space at a major retailer, or a Pepsi distribution friction event.
1-3 year terminal thesis hinges on whether CELH can defend the #3 energy drink slot against Monster/Red Bull and convert Alani Nu into a durable female-skewed franchise without permanent margin damage. If EBITDA can sustain $700M-$1B and FCF $250M+, current $7.3B market cap is reasonable. Biggest structural risk: energy drinks are a fashion category — Celsius itself rocketed from $5 to $95 to $28 in 4 years, showing the brand cycle is brutal. Secondary risk: GLP-1 / health-trend headwinds to functional beverages.
Top line is reaccelerating sharply post-Alani Nu acquisition: Q1 2026 revenue of $782.6M is up materially from $739M (Q2'25) and $725M (Q3'25), with trailing revenue at $2.97B. Gross margin held at 48.3% in Q1'26 (vs 50.4% TTM, 51.5% in Q2'25) — some dilution from the Alani Nu mix and distribution-led growth, consistent with Benzinga's note that margins are under pressure. Operating margin recovered to 18.3% after a noisy 2025 (Q3'25 had a $61M net loss tied to integration/charges). Balance sheet is healthier than it looks: $549M cash vs $669M debt, D/E 22.4 (reported on a scaled basis — actual leverage is moderate given $3.0B equity and $679M EBITDA), current ratio 1.77. FCF generation is real but lumpy ($178M TTM FCF, but Q4'25 was -$130M). Forward P/E of 14x on $2.04 forward EPS is the most compelling fundamental data point — a stark contrast to the 66x trailing multiple, implying the market expects either a sharp earnings rebound or doesn't believe the forward number.
Across all timeframes the actual price (green) is in a clear downtrend and currently pinned near $28.62, just above the 52-week low of $27.66 — a critical support shelf visible on the 1h, 4h, and weekly charts. On the 1h chart the Kronos forecast diverges sharply bullish, projecting a move to ~$34.2 with an excursion toward $42, while the 4h forecast targets $48.6 and the daily targets ~$39.9 — all implying mean reversion off oversold lows. The weekly chart shows the stock has roundtripped from $95+ peaks back to long-term support around $28-30 that held multiple times in prior cycles. Caveat: the structured accuracy data shows Kronos has 71% directional accuracy at 1-day horizon but collapses to 25-33% beyond 4 days, and MAPE rises to 40-50% at weekly horizon — so the aggressive multi-week bullish forecasts should be discounted. Key levels: support $27.66 (52w low, invalidation), resistance $34-35 (recent consolidation top and forecast target), then $40 / $48.
The news flow is mixed but skews to a tactical bounce setup. Benzinga (May 19) explicitly frames recent strength as 'an oversold bounce' with ongoing concern that 'distribution-led growth could keep pressuring margins' — that's the bear pillar. Simply Wall St (May 21) highlights the -35% three-month drawdown and notes the 5-year TSR of 34% reflects an earlier era, signaling the multiple has reset. The Q1 earnings recap is the most important positive: management credits Alani Nu integration, distribution gains, SKU optimization, and a multi-brand strategy (Celsius, Alani Nu, Rockstar) for the beat. Signal: the Q1 numbers and oversold positioning. Noise: the Barfresh/BRFH coverage that keeps appearing is unrelated, and the broader market headlines (crypto, SpaceX) are irrelevant to CELH thesis.
- Alani Nu integration driving Q1'26 revenue to $782.6M and a multi-brand portfolio strategy explicitly cited by CEO Fieldly on the earnings call
- International expansion (Europe, APAC) referenced in the company description — still small base, room to compound
- Rockstar brand added to portfolio (per Q1 call commentary) broadens occasion coverage beyond the core female/fitness Celsius demo
- SKU optimization and distribution gains cited as drivers of Q1 margin recovery to 18.3% operating margin
- Forward EPS of $2.04 vs trailing $0.43 implies ~5x earnings rebound being modeled by sell-side
- Stock is in a confirmed downtrend, -35% over 3 months and -15% in the last month alone, with momentum still negative
- Q3'25 net loss of $61M and Q4'25 FCF of -$130M show integration costs are real and lumpy
- Benzinga explicitly flags that distribution-led growth is pressuring margins — gross margin compressed from 51.5% (Q2'25) to 48.3% (Q1'26)
- Trailing P/E of 66x is still rich; the bull case relies on the forward $2.04 EPS number being credible
- Energy drink category is fashion-driven — CELH's own price history ($5 → $95 → $28) demonstrates brand-cycle risk
- Kronos model accuracy degrades sharply beyond 4 days (25-33% directional, 40%+ MAPE) — do not anchor on multi-week forecast targets
- Short ratio of 3.48 and float of 196M shares mean shorts are engaged; further bad news could accelerate downside
- Total debt $669M and a recent expansion of the balance sheet (assets $3.8B → $5.2B) tied to Alani Nu — leverage is manageable but elevated
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord